Related references
Note: Only part of the references are listed.Persistent challenges with treating multiple myeloma early
Aaron M. Goodman et al.
BLOOD (2021)
Evaluation of exosomal miRNAs as potential diagnostic biomarkers for acute myocardial infarction using next-generation sequencing
Mei Guo et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signalling
Nidhi Gupta et al.
RNA BIOLOGY (2020)
Therapeutic effects of oligo-single-stranded DNA mimicking of hsa-miR-15a-5p on multiple myeloma
Zhongqing Li et al.
CANCER GENE THERAPY (2020)
Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance
Jia Li et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)
miR-143 promotes angiogenesis and osteoblast differentiation by targeting HDAC7
Renkai Wang et al.
CELL DEATH & DISEASE (2020)
miR-144-3pinhibits the proliferation, migration and angiogenesis of multiple myeloma cells by targeting myocyte enhancer factor 2A
Fei Tian et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2020)
Health-related quality of life of patients with multiple myeloma: A real-world study in China
Xiaozhe Li et al.
CANCER MEDICINE (2020)
The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients
Pawel Robak et al.
CANCERS (2020)
Potential diagnostic value of circulating miRNA for multiple myeloma: A meta-analysis
Shuai-Shuai Gao et al.
JOURNAL OF BONE ONCOLOGY (2020)
Multiple Myeloma, Version 3.2021
Shaji K. Kumar et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
BMSC-Derived Exosomal miR-29a Promotes Angiogenesis and Osteogenesis
Guo-dong Lu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Aberrant Expression of Mir-20a in Serum Exosomes of Multiple Myeloma Lead Abnormal Expression of HIF-1 Signaling Pathway Related Proteins
Zhiyao Zhang et al.
BLOOD (2020)
被撤回的出版物: MicroRNA-27 Inhibits Autophagy and Promotes Proliferation of Multiple Myeloma Cells by Targeting the NEDD4/Notch1 Axis (Retracted article. See vol. 11, 2021)
Feifei Che et al.
FRONTIERS IN ONCOLOGY (2020)
c-Myc, RMRP, and miR-34a-5p form a positive-feedback loop to regulate cell proliferation and apoptosis in multiple myeloma
Xichun Xiao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
MicroRNA as a diagnostic biomarker in childhood acute lymphoblastic leukemia; systematic review, meta-analysis and recommendations
Wafaa M. Rashed et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Serum exosomal microRNAs as novel biomarkers for multiple myeloma
Zhi-yao Zhang et al.
HEMATOLOGICAL ONCOLOGY (2019)
Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma
Nidhi Gupta et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
The Role and Function of microRNA in the Pathogenesis of Multiple Myeloma
Hiroshi Handa et al.
CANCERS (2019)
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes
Maria Antonia Frassanito et al.
JOURNAL OF PATHOLOGY (2019)
miRNA-15a, miRNA-16, miRNA-126, miRNA-146a, and miRNA-223 expressions in autologous hematopoietic stem cell transplantation and their impact on engraftment
Mateusz Nowicki et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2018)
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance
Robert A. Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The diagnostic and prognostic value of plasma microRNA-125b-5p in patients with multiple myeloma
Yanxia Jiang et al.
ONCOLOGY LETTERS (2018)
Multiple Myeloma Exemplifies a Model of Cancer Based on Tissue Disruption as the Initiator Event
Jean-Pascal Capp et al.
FRONTIERS IN ONCOLOGY (2018)
Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma
Seung-Hyun Jung et al.
HAEMATOLOGICA (2017)
Oncogenic role of microRNA-20a in human multiple myeloma
Ting Wang et al.
ONCOTARGETS AND THERAPY (2017)
An integrated bioinformatical analysis of miR-19a target genes in multiple myeloma
Hongyan Lv et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma
Seung-Hyun Jung et al.
HAEMATOLOGICA (2017)
MicroRNA Transfer Between Bone Marrow Adipose and Multiple Myeloma Cells
Luna Soley et al.
CURRENT OSTEOPOROSIS REPORTS (2017)
Multiple myeloma
Shaji K. Kumar et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Expression of Peripheral Blood miRNA-720 and miRNA-1246 Can Be Used as a Predictor for Outcome in Multiple Myeloma Patients
Yuyue Ren et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2017)
Identification of a novel microRNA, miR-4449, as a potential blood based marker in multiple myeloma
Xianjuan Shen et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Prognostic role of circulating exosomal miRNAs in multiple myeloma
Salomon Manier et al.
BLOOD (2017)
miRNA-202 in bone marrow stromal cells affects the growth and adhesion of multiple myeloma cells by regulating B cell-activating factor
Xianjuan Shen et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2016)
MicroRNAs: A Puzzling Tool in Cancer Diagnostics and Therapy
Barbara D'Angelo et al.
ANTICANCER RESEARCH (2016)
A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis
L. Zhang et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2016)
Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis
Mu Hao et al.
ONCOTARGET (2016)
Identification of Circulating Serum microRNAs As Novel Biomarkers Predicting Disease Progression and Sensitivity to Bortezomib Treatment in Multiple Myeloma
Tomoko Narita et al.
BLOOD (2016)
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo
E. Morelli et al.
LEUKEMIA (2015)
Microvesicles from platelets: novel drivers of vascular inflammation
Tanja Vajen et al.
THROMBOSIS AND HAEMOSTASIS (2015)
A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma
Alfons Navarro et al.
ONCOTARGET (2015)
Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma
Chonglei Bi et al.
ONCOTARGET (2015)
MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma
Fei Li et al.
ONCOTARGET (2015)
Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma
Mu Hao et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance
Lenka Kubiczkova et al.
HAEMATOLOGICA (2014)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
Circulating miRNA markers show promise as new prognosticators for multiple myeloma
A. Rocci et al.
LEUKEMIA (2014)
Circulating microRNA 483-5p as a novel biomarker for diagnosis survival prediction in multiple myeloma
Xiaoyan Qu et al.
MEDICAL ONCOLOGY (2014)
miR-202 expression concentration and its clinical significance in the serum of multiple myeloma patients
Jiajia Yu et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2014)
Circulating microRNAs in hematological diseases: principles, challenges, and perspectives
Sarah Grasedieck et al.
BLOOD (2013)
MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease
Maarten Hulsmans et al.
CARDIOVASCULAR RESEARCH (2013)
Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression
Megan Y. Murray et al.
CELL CYCLE (2013)
Serum miR-29a as a marker of multiple myeloma
Sabina Sevcikova et al.
LEUKEMIA & LYMPHOMA (2013)
Lower Plasma Mir-92a Levels Predict Shorter Progression-Free Survival In Newly Diagnosed Symptomatic Multiple Myeloma Patients
Seiichiro Yoshizawa et al.
BLOOD (2013)
Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma
C. I. Jones et al.
BRITISH JOURNAL OF CANCER (2012)
Microparticles: major transport vehicles for distinct microRNAs in circulation
Philipp Diehl et al.
CARDIOVASCULAR RESEARCH (2012)
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
Maria T. Di Martino et al.
CLINICAL CANCER RESEARCH (2012)
Impact of serum storage conditions on microRNA stability
S. Grasedieck et al.
LEUKEMIA (2012)
Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma
Jing-jing Huang et al.
MEDICAL ONCOLOGY (2012)
Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders
S. Yoshizawa et al.
BLOOD CANCER JOURNAL (2012)
Epigenetic silencing of MIR203 in multiple myeloma
Kwan-Yeung Wong et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression
Mu Hao et al.
LEUKEMIA & LYMPHOMA (2011)
Racial disparities in incidence and outcome in multiple myeloma: a population-based study
Adam J. Waxman et al.
BLOOD (2010)
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
R. A. Kyle et al.
LEUKEMIA (2010)
Targeted deletion reveals essential and overlapping functions of the miR-17∼92 family of miRNA clusters
Andrea Ventura et al.
CELL (2008)
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
Flavia Pichiorri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
Review of 1027 patients with newly diagnosed multiple myeloma
RA Kyle et al.
MAYO CLINIC PROCEEDINGS (2003)
Share Paper
